Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Retigabine Solution, 1.0 mg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco R0181ML
Description
Retigabine, also known as ezogabine, is a new antiepileptic drug developed for treatment of partial seizures. The drug is marketed under the trade names Potiga in the US and Trobalt in the EU. This certified solution standard is suitable for use as starting material in calibrators and controls for LC/MS or GC/MS methods in clinical toxicology, forensic analysis, urine drug testing, pain prescription monitoring, or pharmaceutical research applications.Specifications
75-05-8, 150812-12-7 | |
MFCD04307735 | |
1.0 mg/mL in acetonitrile | |
Ampule | |
6°C (42.8°F) - closed cup (solvent) |
C16H18FN3O2 | |
UN 1648 3 / PGII | |
303.33 | |
1 mL |
Safety and Handling
H332-H319-H412
H312
EINECSNumber : 200-835-2
Recommended Storage : -20°C
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation
Spot an opportunity for improvement?
Provide Content Correction